Japan's dark side to progress
the struggle for justice for pharmaceutical victims of Japan's post war economic boom
| LEADER | cam a22 u 4500 | ||
|---|---|---|---|
| 001 | 260881325 | ||
| 003 | CHVBK | ||
| 005 | 20201011233730.0 | ||
| 008 | 130816s1991 ja | 00 |eng|d | ||
| 024 | 7 | |a http://catalogue.bnf.fr/ark:/12148/cb355154620 |2 uri | |
| 035 | |a (NEBIS)000629447 | ||
| 035 | |a (IDSBB)000799368 | ||
| 035 | |a (RERO)1518960 | ||
| 035 | |a (VAUD)991001907539702852 | ||
| 035 | |a (LIBIB)000049519 | ||
| 035 | |a (RNV)001387635-41bculausa_network | ||
| 035 | |a (RERO)001387635 | ||
| 035 | |a 1518960 | ||
| 035 | |a (EXLNZ-41BCULAUSA_NETWORK)991009329839702851 | ||
| 040 | |a ETH-BIB |b ger |c ETH-BIB |e ETHICS-ISBD | ||
| 072 | 7 | |a s1dr |2 rero | |
| 072 | 7 | |a s2pa |2 rero | |
| 082 | 1 | |a 320 |2 15 | |
| 082 | 1 | |a 340 |2 15 | |
| 084 | |a 316.32(520) |a BCUDsm |2 CLASBCUD | ||
| 100 | 1 | |a Gotō |D Takanori | |
| 245 | 1 | 0 | |a Japan's dark side to progress |b the struggle for justice for pharmaceutical victims of Japan's post war economic boom |c by Takanori Goto |
| 260 | |a Chiba, Japan |b Manbousha Publications |c 1991 | ||
| 300 | |a XIII, 180 S. |c 19 cm | ||
| 583 | |5 labcud TVA 56402 |z 3 | ||
| 650 | 7 | |a Pharmazeutische Industrie |2 idszbz | |
| 650 | 7 | |a HEILMITTELRECHT + PHARMARECHT + MEDIZINRECHT (SPEZIELLE RECHTSZWEIGE) |x ger |0 (ETHUDK)000011578 |2 ethudk | |
| 650 | 7 | |a JAPAN (OSTASIEN). STAAT. NIPPO) |x ger |0 (ETHUDK)000006330 |2 ethudk | |
| 650 | 7 | |a NEBENWIRKUNGEN VON ARZNEIMITTELN + BEHANDLUNGSKOMPLIKATIONEN |x ger |0 (ETHUDK)000026653 |2 ethudk | |
| 650 | 7 | |a Arzneimittelhaftung |z Japan |2 idsbb | |
| 650 | 7 | |a Industrie |0 (RERO)A021017052 |2 rero | |
| 650 | 7 | |a Médicaments |0 (RERO)A021002158 |2 rero | |
| 650 | 7 | |a Victimes |0 (RERO)A021020630 |2 rero | |
| 650 | 7 | |a industrie |x produit pharmaceutique |x victime |z Japon |2 chrero | |
| 651 | 7 | |a Japan |2 idszbz | |
| 651 | 7 | |a Japon |0 (RERO)A010100368 |2 rero | |
| 655 | 7 | |a Kritische Darstellung |2 idszbz | |
| 691 | 7 | |B u |a HEILMITTELRECHT + PHARMARECHT + MEDIZINRECHT (SPEZIELLE RECHTSZWEIGE) |z ger |u 349.83 |2 nebis E1 | |
| 691 | 7 | |B u |a JAPAN (OSTASIEN). STAAT. NIPPON |z ger |u (52) |2 nebis E1 | |
| 691 | 7 | |B u |a NEBENWIRKUNGEN VON ARZNEIMITTELN + BEHANDLUNGSKOMPLIKATIONEN |z ger |u 615.06 |2 nebis E1 | |
| 691 | 7 | |B u |a PHARMA LAW + HEALTH CARE LAW + PHARMACY LAW (SPECIAL LAW BRANCHES) |z eng |u 349.83 |2 nebis E1 | |
| 691 | 7 | |B u |a DROIT DE LA PHARMACIE + DROIT PHARMACEUTIQUE + DROIT DE LA MÉDICINE (BRANCHES SPÉCIALES DU DROIT) |z fre |u 349.83 |2 nebis E1 | |
| 691 | 7 | |B u |a JAPAN (EAST ASIA). STATE. NIPPON |z eng |u (52) |2 nebis E1 | |
| 691 | 7 | |B u |a JAPON (ASIE DE L'EST). ÉTAT. NIPPON |z fre |u (52) |2 nebis E1 | |
| 691 | 7 | |B u |a SIDE EFFECTS OF DRUGS + COMPLICATIONS DURING TREATMENT |z eng |u 615.06 |2 nebis E1 | |
| 691 | 7 | |B u |a EFFETS SECONDAIRES DES MÉDICAMENTS + COMPLICATIONS DU TRAITEMENT |z fre |u 615.06 |2 nebis E1 | |
| 691 | 7 | |B u |u (520) |a Japan |2 libib XD | |
| 691 | 7 | |B u |u 343.347 |a Strafbare Handlungen gegen die öffentliche Gesundheit |2 libib XD | |
| 691 | 7 | |B u |u 615.1 |a Pharmazie |2 libib XD | |
| 700 | 1 | |a Goto |D Takanori | |
| 898 | |a BK020000 |b XK020000 |c XK020000 | ||
| 912 | 7 | |a ra |2 SzZuIDS BS/BE | |
| 912 | 7 | |a po |2 SzZuIDS BS/BE | |
| 912 | 7 | |a me |2 FL | |
| 912 | 7 | |a rs |2 FL | |
| 949 | |B RERO |F RE61001 |b RE61001 |c RE610010023 |j BGE Sf 4606 | ||
| 949 | |B VAUD |F bcud |b bcud |j TVA 56402 316.32(520) |c 810010047 | ||
| 949 | |B LIBIB |F FLLB |b FLLB |c MA |j PX 8365 |x Akz: va/lbfl/D/73547 | ||
| 949 | |B NEBIS |F Z01 |b Z01 |c 03 |j GE 6847 | ||
| 949 | |B IDSBB |F A100 |b A100 |c MAG |j UBH ni 7601 |x Akz: ba/uub-/g/92 | ||
| 949 | |B NEBIS |F E01 |b E01 |c MG |j 521038 | ||
| 950 | |B NEBIS |P 100 |E 1- |a Gotō |D Takanori | ||
| 950 | |B NEBIS |P 700 |E 1- |a Goto |D Takanori | ||
| 950 | |B IDSBB |P 100 |E 1- |a Goto |D Takanori | ||
| 950 | |B RERO |P 100 |E 1- |a Goto |D Takanori |0 (RERO)A003310370 |4 cre | ||
| 950 | |B VAUD |P 100 |E 1- |a Goto |D Takanori |4 aut | ||
| 950 | |B LIBIB |P 100 |E 1- |a Goto |D Takanori | ||